Clinical trial
Hydroxychloroquine for the Management of CVD in CKD
NCT03636152 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxychloroquine for the Management of CVD in CKD
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 14, 2018
- Completion date
- January 31, 2024
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stiffness, atherosclerosis, cardiovascular disease, chronic kidney disease, inflammation